Medical Hypotheses
Volume 65, Issue 1 , Pages 8-16, 2005

The sweet thing about Type 1 diabetes: A cryoprotective evolutionary adaptation

  • S. Moalem

      Affiliations

    • Department of Pathology, Mount Sinai School of Medicine, Box 1134, New York, NY 10029, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 917 913 3723
  • ,
  • K.B. Storey

      Affiliations

    • Institute of Biochemistry, Carleton University, Ottawa, Ont., Canada
  • ,
  • M.E. Percy

      Affiliations

    • Neurogenetics Laboratory, Surrey Place Centre, Toronto, Ont., Canada
    • Departments of Physiology and Obstetrics and Gynaecology, University of Toronto, Toronto, Ont., Canada
  • ,
  • M.C. Peros

      Affiliations

    • Department of Geography, University of Toronto, Toronto, Ont., Canada
  • ,
  • D.P. Perl

      Affiliations

    • Department of Pathology, Mount Sinai School of Medicine, Box 1134, New York, NY 10029, USA

Received 21 November 2004; accepted 29 December 2004. published online 29 March 2005.

Summary 

The reasons for the uneven worldwide distribution of Type 1 diabetes mellitus have yet to be fully explained. Epidemiological studies have shown a higher prevalence of Type 1 diabetes in northern Europe, particularly in Scandinavian countries, and Sardinia. Recent animal research has uncovered the importance of the generation of elevated levels of glucose, glycerol and other sugar derivatives as a physiological means for cold adaptation. High concentrations of these substances depress the freezing point of body fluids and prevent the formation of ice crystals in cells through supercooling, thus acting as a cryoprotectant or antifreeze for vital organs as well as in their muscle tissue. In this paper, we hypothesize that factors predisposing to elevated levels of glucose, glycerol and other sugar derivatives may have been selected for, in part, as adaptive measures in exceedingly cold climates. This cryoprotective adaptation would have protected ancestral northern Europeans from the effects of suddenly increasingly colder climates, such as those believed to have arisen around 14,000 years ago and culminating in the Younger Dryas. When life expectancy was short, factors predisposing to Type 1 diabetes provided a survival advantage. However, deleterious consequences of this condition have become significant only in more modern times, as life expectancy has increased, thus outweighing their protective value. Examples of evolutionary adaptations conferring selection advantages against human pathogens that result in deleterious effects have been previously reported as epidemic pathogenic selection (EPS). Such proposed examples include the cystic fibrosis mutations in the CFTR gene bestowing resistance to Salmonella typhi and hemochromatosis mutations conferring protection against iron-seeking intracellular pathogens. This paper is one of the first accounts of a metabolic disorder providing a selection advantage not against a pathogenic stressor alone, but rather against a climatic change. We thus believe that the concept of EPS should now include environmental factors that may be nonorganismal in nature. In so doing we propose that factors resulting in Type 1 diabetes be considered a result of environmental pathogenic selection (EnPS).

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0306-9877(05)00054-X

doi:10.1016/j.mehy.2004.12.025

Medical Hypotheses
Volume 65, Issue 1 , Pages 8-16, 2005